Login to Your Account

Despite Modafinil, FTC Woes

Anti-Emetics Could Be Next In Cephalon's Oncology Bid

By Randall Osborne

Monday, August 28, 2006
No Abstract

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription